AbbVie has solidified its reputation among dividend-paying stocks, having increased its dividend by 265.1% since its inception in 2013, indicating strong financial health and commitment to shareholders.
With a current stock price of $194.61, AbbVie offers a dividend yield of 3.19%. This appealing figure attracts both growth and income-oriented investors.
If you had invested $1,000 in AbbVie at its inception in January 2013, your initial 28.6 shares would now be worth about $5,566.85, demonstrating substantial growth.
Wall Street analysts have a positive outlook on AbbVie, with a consensus 'Outperform' rating and a modest 8.8% upside to the consensus price target of $199.64.
Collection
[
|
...
]